News from ani pharmaceuticals, inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:ENDP)

Mar 04, 2014, 16:50 ET

ANI Pharmaceuticals Announces Proposed Public Offering Of Common Stock

 ANI Pharmaceuticals, Inc. (the "Company") (NASDAQ:  ANIP) today announced that it intends to offer its common stock in a registered...

Feb 18, 2014, 08:30 ET

ANI Pharmaceuticals Reports Record Net Revenues of $10.5 million, EPS from continuing operations of $0.35, and Adjusted Non-GAAP EBITDA of $3.9 Million for the Fourth Quarter Ended December 31, 2013

ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported financial results for the three and twelve months ended December 31, 2013. Fourth...

Feb 06, 2014, 08:00 ET

ANI Pharmaceuticals Schedules Conference Call for Fourth Quarter and Full Year 2013 Financial Results

 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its fourth quarter and full year 2013 financial...

Jan 06, 2014, 08:00 ET

ANI Pharmaceuticals Enters Development Agreement for Generic Drug Product with Sterling Pharmaceutical Services

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), an emerging generic pharmaceutical company, today announced that it has entered into a...

Dec 26, 2013, 16:30 ET

ANI Pharmaceuticals Acquires 31 Generic Drug Products from Teva Pharmaceuticals

 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), an emerging generic pharmaceutical company, today announced that it has acquired 31 previously...

Dec 10, 2013, 20:00 ET

ANI Pharmaceuticals Presents At Oppenheimer 24th Annual Healthcare Conference

 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) presented at the Oppenheimer & Co. 24th Annual Healthcare Conference at the Crowne Plaza Hotel in...

Nov 15, 2013, 08:00 ET

ANI Pharmaceuticals To Present At Oppenheimer 24th Annual Healthcare Conference On December 10, 2013

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) will be presenting at the Oppenheimer & Co. 24th Annual Healthcare Conference.  The Conference...

Nov 07, 2013, 08:00 ET

ANI Pharmaceuticals Reports Net Revenues of $7.8 million, adjusted Non-GAAP EBITDA of $1.7 Million, and EPS of $0.13 for the Third Quarter Ended September 30, 2013

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) today reported results for the three and nine months ended September 30, 2013. Third quarter and...

Oct 29, 2013, 08:00 ET

ANI Pharmaceuticals, Inc. Announces Date for Third Quarter 2013 Earnings Release

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) will release its third quarter 2013 earnings before the market opens on Thursday, November 7th,...

Aug 12, 2013, 08:00 ET

ANI Pharmaceuticals Announces an Agreement for the Development and Marketing of an Oral Soft Gel Prescription Product with Sofgen Pharmaceuticals

 ANI Pharmaceuticals (NASDAQ: ANIP) today announced that it has signed a binding letter of intent for the development of an oral soft gel...

Aug 09, 2013, 08:00 ET

ANI Pharmaceuticals Reports Net Revenues of $6.2 million and adjusted non-GAAP EBITDA of $1.2 Million for the Second Quarter Ended June 30, 2013

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) today reported results for the three and six months ended June 30, 2013. Second quarter and first half...

Jul 23, 2013, 08:00 ET

ANI Pharmaceuticals, Inc. Announces Receipt of NASDAQ Listing Approval

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that it received a letter from NASDAQ informing ANI that its application for initial...

Jul 22, 2013, 08:00 ET

ANI Pharmaceuticals, Inc. Announces Date for Second Quarter 2013 Earnings Release

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) will release its second quarter 2013 earnings before the market opens on Friday, August 9th,...

Jul 18, 2013, 08:00 ET

ANI Pharmaceuticals Announces Name Change and Reverse Stock Split

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today the change of its name from BioSante Pharmaceuticals, Inc.   In connection with...